References and Notes
<A NAME="RD10807ST-1A">1a</A>
Armstrong RW.
Combs AP.
Tempst PA.
Brown SD.
Keating TA.
Acc. Chem. Res.
1996,
29:
123
<A NAME="RD10807ST-1B">1b</A>
Ugi I.
Domling A.
Werner B.
J. Heterocycl. Chem.
2000,
37:
647
<A NAME="RD10807ST-1C">1c</A>
Weber L.
Illgen K.
Almstetter M.
Synlett
1999,
366
<A NAME="RD10807ST-1D">1d</A>
Kamijo S.
Yamamoto Y.
J. Am. Chem. Soc.
2002,
124:
11940
<A NAME="RD10807ST-1E">1e</A>
Domling A.
Ugi I.
Angew. Chem. Int. Ed.
2000,
39:
3169
<A NAME="RD10807ST-1F">1f</A>
Cao C.
Shi Y.
Odom AL.
J. Am. Chem. Soc.
2003,
125:
2880
<A NAME="RD10807ST-1G">1g</A>
Zani L.
Bolm C.
Chem. Commun.
2006,
4263
<A NAME="RD10807ST-2">2</A>
Wei C.
Zhang L.
Li CJ.
Synlett
2004,
1472
<A NAME="RD10807ST-3A">3a</A>
Naota I.
Takaya H.
Murahashi SI.
Chem. Rev.
1998,
98:
2599
<A NAME="RD10807ST-3B">3b</A>
Dyker G.
Angew. Chem. Int. Ed.
1999,
38:
1698
<A NAME="RD10807ST-4A">4a</A>
Yan W.
Wang R.
Xu Z.
Xu J.
Lin L.
Shen Z.
Zhou Y.
J. Mol. Catal. A: Chem.
2006,
255:
81
<A NAME="RD10807ST-4B">4b</A>
Zhang Y.
Santos AM.
Herdtweck E.
Mink J.
Kuhn FE.
New. J. Chem.
2005,
29:
366
<A NAME="RD10807ST-4C">4c</A>
Wei C.
Li Z.
Li CJ.
Org. Lett.
2003,
5:
4473
<A NAME="RD10807ST-5A">5a</A>
Wei C.
Li Z.
Li CJ.
Synlett
2004,
1472
<A NAME="RD10807ST-5B">5b</A>
Wei C.
Li CJ.
J. Am. Chem. Soc.
2003,
125:
9584
<A NAME="RD10807ST-6">6</A>
Lo VKY.
Liu Y.
Wong MK.
Che CM.
Org. Lett.
2006,
8:
1529
<A NAME="RD10807ST-7A">7a</A>
Shi L.
Tu YQ.
Wang M.
Zhang FM.
Fan CA.
Org. Lett.
2004,
6:
1001
<A NAME="RD10807ST-7B">7b</A>
Syeda HZS.
Halder R.
Karla SS.
Das J.
Iqbal J.
Tetrahedron Lett.
2002,
43:
6485
<A NAME="RD10807ST-7C">7c</A>
Kabalka GW.
Wang L.
Pagni RM.
Synlett
2001,
676
<A NAME="RD10807ST-8">8</A>
Li CJ.
Wei C.
Chem. Commun.
2002,
268
<A NAME="RD10807ST-9">9</A>
Li Z.
Wei C.
Chen L.
Varma RS.
Li CJ.
Tetrahedron Lett.
2004,
45:
2443
<A NAME="RD10807ST-10">10</A>
Park SB.
Alper H.
Chem. Commun.
2005,
1315
<A NAME="RD10807ST-11">11</A>
Choudary BM.
Sridhar C.
Kantam ML.
Sreedhar B.
Tetrahedron Lett.
2004,
45:
7319
<A NAME="RD10807ST-12">12</A>
Kantam ML.
Prakash BV.
Reddy CRV.
Sreedhar B.
Synlett
2005,
2329
<A NAME="RD10807ST-13">13</A>
Reddy KM.
Babu NS.
Prasad PSS.
Lingaiah N.
Tetrahedron Lett.
2006,
47:
7563
<A NAME="RD10807ST-14">14</A>
Kidwai M.
Bansal V.
Kumar A.
Mozumdar S.
Green Chem.
2007, in press
<A NAME="RD10807ST-15A">15a</A>
Mizuno N.
Misono M.
Chem. Rev.
1998,
98:
199
<A NAME="RD10807ST-15B">15b</A>
Sartori G.
Ballini R.
Bigi F.
Bosica G.
Maggi R.
Righi P.
Chem. Rev.
2004,
104:
199
<A NAME="RD10807ST-16">16</A>
Corma A.
Garcia H.
Adv. Synth. Catal.
2006,
348:
1391
<A NAME="RD10807ST-17">17</A>
Likhar PR.
Roy S.
Roy M.
Kantam ML.
De R L.
J. Mol. Catal. A: Chem.
2007, in press
<A NAME="RD10807ST-18">18</A>
Preparation of Imine-Modified Silica-Supported Copper Catalysts:17
SiO
2
-Py-Cu(OAc)
2
: SiO2-Py (1 g) was stirred with a solution of Cu(OAc)2 (1 mmol) in acetone (25 mL) for 24 h to get SiO2-Py-(CuOAc)2. The copper content was measured by ICP-AES and it was found to be 0.43 mmol/g. Similarly
SiO2-Sal-Cu(OAc)2 (Cu: 0.41 mmol/g), SiO2-BPy-Cu(OAc)2 (Cu: 0.39 mmol/g), and SiO2-Thio-Cu(OAc)2 (Cu: 0.41 mmol/g) were prepared from Cu(OAc)2 in acetone. SiO2-Py-CuCl2 (Cu: 0.47 mmol/g) was prepared from an acetone solution of CuCl2. SiO2-Py-CuI was prepared from a MeCN solution of CuI and the copper content was 0.45 mmol/g.
<A NAME="RD10807ST-19">19</A>
Typical Procedure for A
³
Coupling Reaction: A mixture of aldehyde (1 mmol), amine (1.2 mmol), alkyne (1.5 mmol) and SiO2-Py-CuI (110 mg, 5 mol%) in MeCN (3 mL) was stirred in a round-bottomed flask at 90
°C under nitrogen. After completion of the reaction (monitored by TLC) the catalyst
was filtered. After removing the solvent at reduced pressure, the crude material was
purified by chromatography on silica gel using hexane-EtOAc mixture as eluent to afford
the corresponding propargylamines. Spectroscopic data of the new compounds are given
below:
Diallyl-[1-(4-bromophenyl)-3-phenylprop-2-ynyl]amine (Table 3, entry 12): 1H NMR (300 MHz, CDCl3): δ = 7.40-7.62 (m, 6 H), 7.28-7.38 (m, 3 H), 5.70-5.91 (m, 2 H), 5.24 (d, J = 17.0 Hz, 2 H), 5.12 (d, J = 9.3 Hz, 2 H), 4.99 (s, 1 H), 3.16-3.29 (m, 2 H), 2.90-3.06 (m, 2 H). 13C NMR (75 MHz, CDCl3): δ = 138.5, 136.3, 131.8, 131.1, 129.8, 128.4, 122.8, 121.4, 117.4, 88.1, 84.7,
55.9, 53.5. ESI-MS: m/z = 368 [M + 1], 366 [M + 1], 271, 269, 146, 104. Anal. Calcd for C19H20BrN: C, 66.67; H, 5.89; N, 4.09. Found: C, 66.71; H, 5.92; N, 4.01.
4-[1-(4-Bromophenyl)-3-
p
-tolylprop-2-ynyl]morpholine (Table 3, entry 16): 1H NMR (300 MHz, CDCl3): δ = 7.45-7.61 (m, 4 H), 7.37 (d, J = 8.0 Hz, 2 H), 7.12 (d, J = 8.0 Hz, 2 H), 4.69 (s, 1 H), 3.61-3.79 (m, 4 H), 2.52-2.68 (m, 4 H), 2.38 (s, 3
H). 13C NMR (75 MHz, CDCl3): δ = 138.5, 137.1, 131.8, 131.3, 130.3, 129.0, 121.7, 119.8, 89.1, 83.5, 67.2, 61.4,
49.8, 21.4. EI-MS: m/z = 371 [M+], 369 [M+], 285, 283, 214, 205, 189, 128, 86, 56. Anal. Calcd for C20H20BrNO: C, 64.87; H, 5.44; N, 3.78. Found: C, 64.89; H, 5.47; N, 3.75.